Asia-Pacific Stents Market, By Product (Coronary Stents, Peripheral Stents, Stent-Related Implants), Biomaterial (Metallic Biomaterials, Polymeric Biomaterials, Natural Biomaterials), End User (Hospital, Cardiac Centers, Others), Country (Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific)- Industry Trends and Forecast to 2028
Market Analysis and Insights: Asia-Pacific Stents Market
The Asia-Pacific stents market is expected to witness market growth at a rate of 5.5% in the forecast period of 2021 to 2028. Data Bridge Market Research report on stents market provides analysis and insights regarding the various factors expected to be prevalent throughout the forecast period while providing their impacts on the market’s growth. The rise in healthcare sector globally is escalating the growth of stents market.
Stents refer to the pipe of fiber or metal that is inserted in the lumen to clear the channel. These instruments are utilized in clinics, heart centers and hospitals for various purposes such as the widening of blood vessels and during procedures. Stents are generally graded as cardiac, peripheral interventions or implants that are attached to stents. The length and material of the stent depends on the body part.
The rise in the prevalence of obesity among population acts as one of the major factors driving the growth of stents market. The rise in the preference for minimally invasive surgeries (MIS) owning to various advantages such as small incision wounds, quick recovery and shorter hospital stays, and increased number of percutaneous coronary intervention (PCI) procedures accelerate the market growth. The increase in prevalence of cardiovascular diseases (CVDs), such as stroke and heart attack, and introduction of advanced DES and evolving bioresorbable scaffolds further influence the market. Additionally, development in the healthcare infrastructure, surge in healthcare expenditure and funds by public-private organizations positively affects the stents market. Furthermore, advancements in stenting technology extend profitable opportunity to the market players in the forecast period of 2021 to 2028.
On the other hand, high cost associated with the treatment with stents implants is expected to obstruct the market growth. Compliance and stringent clearance of stents are projected to challenge the stents market in the forecast period of 2021-2028.
This stents market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on stents market Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Asia-Pacific Stents Market Scope and Market Size
The stents market is segmented on the basis of product, biomaterial and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
- On the basis of product, the stents market is segmented into coronary stents, peripheral stents, and stent-related implants. Coronary stents are further segmented into drug-eluting stents (des), bare-metal coronary stents and bioabsorbable stents. Peripheral stents are further segmented into iliac stents, femoral-popliteal stents, renal & related stents and carotid stents. Stent-related implants are further segmented into synthetic grafts and vena cava filters.
- On the basis of biomaterial, the stents market is segmented into metallic biomaterials, polymeric biomaterials, and natural biomaterials.
- On the basis of end user, the stents market is segmented into hospital, cardiac centers and others.
Asia-Pacific Stents Market Country Level Analysis
The stents market is analyzed and market size insights and trends are provided by country, product, biomaterial and end user as referenced above.
The countries covered in the Asia-Pacific stents market report are China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, and Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC).
Japan dominates the Asia-Pacific stents market owning to the technological advancements in the region. China is expected to witness high growth during the forecast period of 2021 to 2028 because of the growing demand for advanced stents.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare infrastructure growth installed base and new technology penetration
Asia-Pacific stents market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for Asia-Pacific stents market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the Asia-Pacific stents market. The data is available for historic period 2010-2019.
Competitive Landscape and Asia-Pacific Intraoperative Imaging Market Share Analysis
The stents market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to stents market.
The major players covered in the stents market report are Medtronic, Boston Scientific Corporation, Johnson & Johnson Services, Inc., BD, Biotronik, MicroPort Scientific Corporation., Biosensors International Group, Ltd., Teleflex Incorporated, Vascular Concept., Cook , Merit Medical Systems., Terumo Corporation, Fuji Systems, SMT, B. Braun Melsungen AG, and Abbott, among others. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
SKU-